Identification of multi-SH3 domain-containing protein interactome in pancreatic cancer: a yeast two-hybrid approach

Subhash Thalappilly1, Muhtadi Suliman, Odile Gayet

  • 1INSERM U624, Stress Cellulaire, Marseille, France.

Proteomics
|July 26, 2008
PubMed

Insights

Pancreatic ductal adenocarcinoma (PDAC) involves complex signaling pathways. This study identifies key scaffold proteins and their interactions, offering new therapeutic targets for this challenging cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with limited treatment options.
  • Signal transduction networks are crucial in PDAC progression, making their components important therapeutic targets.

Purpose of the Study:

  • To investigate the role of multidomain scaffold proteins, particularly those with multiple Src homology 3 (SH3) domains, in PDAC.
  • To identify novel protein interactions and complexes involving these scaffold proteins in pancreatic cancer cells.

Main Methods:

  • Microarray-based analysis to identify expressed SH3 domain-containing scaffold proteins in PDAC cells.
  • Yeast two-hybrid approach to discover protein-protein interactions with these identified scaffold proteins.

Main Results:

  • Thirteen multiple SH3 domain-containing scaffold proteins were found to be expressed in PDAC cells.
  • Interactions were identified with proteins involved in cell proliferation (CIZ1, BIRC6, RBBP6), signaling (LTBP4, Notch2, TOM1L1, STK24), and membrane dynamics (PLSCR1, DDEF2, VCP).

Conclusions:

  • Multi-SH3 domain-containing proteins mediate interactions forming dynamic complexes crucial for pancreatic cancer cell signaling.
  • These identified protein complexes are vital for understanding PDAC biology and developing new therapeutic strategies.